Novo Nordisk Appoints U.S. Pharma Executive Greg Miley as Global Head of Corporate Affairs

Gelonghui October 20th | Novo Nordisk has appointed Greg Miley, a senior executive from the U.S. pharmaceutical industry, as its new Global Head of Corporate Affairs to address pressure from U.S. President Trump on drug pricing. Miley most recently served as Senior Vice President of Government Affairs at U.S. pharmaceutical giant AbbVie. A spokesperson for Novo Nordisk stated that Miley will join the company in early November and will be responsible for global communications and global public affairs.